Woerle HJ

References (5)

Title : Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study - McGill_2013_Diabetes.Care_36_237
Author(s) : McGill JB , Sloan L , Newman J , Patel S , Sauce C , von Eynatten M , Woerle HJ
Ref : Diabetes Care , 36 :237 , 2013
Abstract : McGill_2013_Diabetes.Care_36_237
ESTHER : McGill_2013_Diabetes.Care_36_237
PubMedSearch : McGill_2013_Diabetes.Care_36_237
PubMedID: 23033241

Title : Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients - Horie_2011_Clin.Ther_33_973
Author(s) : Horie Y , Kanada S , Watada H , Sarashina A , Taniguchi A , Hayashi N , Graefe-Mody EU , Woerle HJ , Dugi KA
Ref : Clin Ther , 33 :973 , 2011
Abstract : Horie_2011_Clin.Ther_33_973
ESTHER : Horie_2011_Clin.Ther_33_973
PubMedSearch : Horie_2011_Clin.Ther_33_973
PubMedID: 21723606

Title : Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects - Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123
Author(s) : Graefe-Mody U , Rose P , Ring A , Zander K , Iovino M , Woerle HJ
Ref : Drug Metab Pharmacokinet , 26 :123 , 2011
Abstract : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123
ESTHER : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123
PubMedSearch : Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123
PubMedID: 21084763

Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409
Author(s) : Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA
Ref : Diabet Med , 27 :1409 , 2010
Abstract : Forst_2010_Diabet.Med_27_1409
ESTHER : Forst_2010_Diabet.Med_27_1409
PubMedSearch : Forst_2010_Diabet.Med_27_1409
PubMedID: 21059094

Title : Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteers - Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652
Author(s) : Graefe-Mody EU , Jungnik A , Ring A , Woerle HJ , Dugi KA
Ref : Int J Clinical Pharmacology & Therapeutics , 48 :652 , 2010
Abstract : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652
ESTHER : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652
PubMedSearch : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652
PubMedID: 20875371